Loading data
GPCRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development expense | 225.26 m USD | 108.81 m USD | 70.1 m USD | 36.19 m USD |
| Operating profit | -176.56 m USD | -158.23 m USD | -102.78 m USD | -52.56 m USD |
| Profit before tax | -140.69 m USD | -122.22 m USD | -89.38 m USD | -51.3 m USD |
| Income tax expense | 515 k USD | 310 k USD | 236 k USD | 17 k USD |
| Net income (reported basis) | -141.2 m USD | -122.53 m USD | -89.62 m USD | -51.32 m USD |
| Net income attributable to common shareholders | — | — | -89.62 m USD | -52.84 m USD |
| Basic earnings per share | -0.8 USD/share | -0.78 USD/share | -0.81 USD/share | -5.51 USD/share |
| Diluted earnings per share | -0.8 USD/share | -0.78 USD/share | -0.81 USD/share | -5.51 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.